v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating activities:      
Net income (loss) from continuing operations $ (141,725) $ (1,124,841) $ 42,803
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation and amortization 152,638 143,978 57,405
Impairment of goodwill 0 1,028,397 0
Share-based compensation expense 13,429 10,188 11,495
Provision for revenue adjustments 3,249 3,635 5,091
Deferred income tax benefit (10,948) (133,510) (8,893)
Impairment of abandoned software project costs 19,765 0 0
Other 11,504 14,917 (1,180)
Changes in operating assets and liabilities, net of effects from the purchase of acquired companies:      
Accounts receivable (18,005) 9,546 30,555
Other receivables (7,365) 9,677 (5,408)
Other current and noncurrent assets (24,422) (15,085) 30,683
Accounts payable, accrued expenses and other liabilities 46,264 (15,917) 36,661
Net cash provided by (used in) operating activities of continuing operations 44,384 (69,015) 199,212
Investing activities:      
Proceeds from sale of property and equipment 2,204 5,137 3,741
Purchases of property and equipment (29,116) (37,060) (30,725)
Purchase of businesses, net of cash acquired 0 (1,576,219) (56,703)
Other 0 (444) 0
Net cash used in investing activities of continuing operations (26,912) (1,608,586) (83,687)
Financing activities:      
Repayments of finance lease obligations (17,305) (18,425) (9,500)
Proceeds from credit facility 110,000 75,000 70,000
Payments on credit facility (110,000) (155,000) (178,500)
Proceeds from long-term debt held in escrow 0 0 1,790,500
Payment of debt issuance costs 0 (52,471) 0
Payment of earn-out liability 0 (12,247) 0
Payments of dividends to shareholders 0 0 (24,995)
Repurchases and retirement of common stock 0 0 (93,811)
Proceeds from common stock issued under employee stock purchase plan 846 753 800
Payment of minimum tax withholdings on share-based awards (1,074) (1,442) (4,340)
Contributions from subsidiary held for sale 0 0 240,572
Net cash provided by (used in) financing activities of continuing operations (17,533) (163,832) 1,790,726
Effect of exchange rate changes on cash 791 1,013 0
Net increase (decrease) in cash, cash equivalents and restricted cash equivalents from continuing operations 730 (1,840,420) 1,906,251
Cash from discontinued operation:      
Net cash used in operating activities of discontinued operations 0 (6,387) (17,824)
Net cash provided by investing activities of discontinued operations 0 0 258,525
Net cash used in financing activities of discontinued operations 0 0 (240,701)
Net increase (decrease) in cash, cash equivalents and restricted cash equivalents 730 (1,846,807) 1,906,251
Cash, cash equivalents, and restricted cash equivalents at beginning of period of continuing operations 105,266 1,952,073 45,822
Cash, cash equivalents, and restricted cash equivalents at end of period of continuing operations 105,996 105,266 1,952,073
Reconciliation of cash, cash equivalents, and restricted cash and restricted cash equivalents:      
Cash and cash equivalents 105,996 104,903 121,969
Restricted cash and restricted cash equivalents 0 363 39,604
Noncurrent restricted cash equivalents 0 0 1,790,500
Total cash, cash equivalents, and restricted cash equivalents shown in the statement of cash flow 105,996 105,266 1,952,073
Non-cash activity:      
Equipment acquired under finance leases $ 12,319 $ 12,404 $ 25,217